DOCSLIB.ORG

Office Gynaecology

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Office Gynaecology O Magazine&G Vol 16 No 3 Spring 2014 Office gynaecology The Royal Australian and New Zealand College of Obstetricians and Gynaecologists Contents Office gynaecology 13 Editorial OMagazine& G Brett Daniels O&G Magazine Advisory Group 14 Contraception: a new focus Dr Gillian Gibson Fellows Rep, New Zealand Suzanne Pearson and Sumudu Cooray A/Prof Stephen Robson Fellows Rep, ACT Dr John Schibeci Diplomates Rep, NSW 17 Hysteroscopic sterilisation Dr Brett Daniels Young Fellows Rep, TAS Dr Alexa Bendall Trainees Rep, QLD Astrid Budden Magazine Editors O&G 21 Mirena: modern-day miracle Penelope Griffiths Julia Serafin Edwina Morgan Lisa Westhaven 24 Colposcopy 2014 Designer and Production Editor Lisa Westhaven Louise Farrell Editorial Communications 26 NCSP renewal: 2016 O&G Magazine Advisory Group, RANZCOG Ian Hammond 254–260 Albert Street EAST MELBOURNE, VIC 3002 Australia 27 Investigating fertility (t) +61 3 9417 1699 Tamara Hunter (f) +61 3 9419 0672 (e) [email protected] 30 Polycystic ovarian syndrome Advertising Sales Megan Ogilvie Bill Minnis Director Minnis Journals (t) +61 3 9836 2808 33 Pelvic inflammatory disease (f) +61 3 9830 4500 Shannon Woodward and Sarah Martin (e) [email protected] Printer 36 Vulval pain: a registrar’s view Highway Press Nicola Quirk (t) +61 3 9887 1388 (f) +61 3 9800 2270 38 Medication management of chronic pelvic pain Susan Evans O&G Magazine authorised by Mr James McAdam © 2014 The Royal 40 Outpatient hysteroscopy Australian and New Zealand College of Obstetricians and Gynaecologists Namiko Kobayashi and Boon Lim (RANZCOG). All rights reserved. No part of this publication may be reproduced or 44 Hysteroscopy: tools, tips, tricks copied in any form or by any means without Khaldoun Aweidah the written permission of the publisher. The submission of articles, news items and letters is 47 Chronic vaginal discharge: causes and management encouraged. Patricia Car For further information about contributing to O&G Magazine visit: www.ranzcog.edu.au/ 52 Heavy and painful periods publications/oandg-magazine.html Ujvala Jagadish and Adam Mackie The statements and opinions expressed in articles, letters and advertisements in O&G 54 Postmenopausal bleeding Magazine are those of the authors and, unless specifically stated, are not necessarily the Adele Zito views of RANZCOG. Although all advertising material is expected to conform to ethical and legal standards, Letter to the editor acceptance does not imply endorsement by 56 Nausea and vomiting in pregnancy the College. Stephen Raymond ISSN 1442-5319 Cover: Shutterstock 76757920 © Sergiu Ungureanu 2 O&G Magazine Contents RANZCOG Regional Committees New Zealand Dr Ian Page Chair Women’s health Jane Cumming Executive Officer 57 Journal Club Level 6 Featherson Tower 23 Waring Taylor Street/ PO Box 10611 Brett Daniels WELLINGTON 6011, NEW ZEALAND (t) +64 4 472 4608 (f) +64 4 472 4609 (e) [email protected] 58 Expecting the unexpected Kellie Wight Australian Capital Territory TBA Chair 61 Alcohol and pregnancy New South Wales Prof Gabrielle Casper Chair Alec Welsh Lee Dawson Executive Officer Suite 4, Level 5, 69 Christie Street ST LEONARDS, NSW 2065 62 Partogram or instagram? (t) +61 2 9436 1688 (f) +61 2 9436 4166 (e) [email protected] Leo Leader Queensland Dr Lee Minuzzo Chair Lee-Anne Harris Executive Officer 66 Q&a: tests and algorithms for ovarian cyst work up Unit 22, Level 3, 17 Bowen Bridge Road HERSTON, QLD 4006 Adam Pendlebury (t) +61 7 3252 3073 (f) +61 7 3257 2370 (e) [email protected] South Australia/Northern Territory The College Dr Roy Watson Chair Tania Back Executive Officer 5 From the President 1–54 Palmer Place/PO Box 767 NORTH ADELAIDE, SA 5006 Michael Permezel (t) +61 8 8267 4377 (f) +61 8 8267 5700 (e) [email protected] 9 From the College Tasmania Dr Emily Hooper Chair James McAdam Mathew Davies Executive Officer College House 254–260 Albert Street 68 Visitors from the Pacific EAST MELBOURNE, VIC 3002 (t) +61 3 9663 5606 (f) + 61 3 9662 3908 Carmel Walker (e) [email protected] Victoria 69 Notice of deceased Fellows Dr Alison Fung Chair Mathew Davies Executive Officer 71 Staff news College House 254–260 Albert Street 72 Obituaries EAST MELBOURNE, VIC 3002 (t) +61 3 9663 5606 (f) + 61 3 9662 3908 (e) [email protected] Western Australia Dr Tamara Walters Chair Janet Davidson Executive Officer Level 1, 44 Kings Park Road WEST PERTH, WA 6005/PO Box 6258 EAST PERTH, WA 6892 (t) +61 8 9322 1051 (f) +61 8 6263 4432 (e) [email protected] The Royal Australian and New Zealand College of Obstetricians and Gynaecologists College House 254–260 Albert Street EAST MELBOURNE, VIC 3002 (t) +61 3 9417 1699 (f) +61 3 9417 0672 (e) [email protected] (w) www.ranzcog.edu.au President Prof Michael Permezel Vice Presidents Board Members A/Prof Stephen Robson Prof Ian Symonds Dr Vijay Roach Dr Sarah Tout Dr John Tait Treasurer Chief Executive Officer Dr Martin Ritossa Mr James McAdam Vol 16 No 3 Spring 2014 3 The College From the President Given the forthcoming joint Selection for specialist training RANZCOG/RCOG Scientific I write this on a fine Saturday morning, receiving news from our Meeting in Brisbane, in April 2015, prospective Trainees as to whether they have or have not been and the Sydney ASM, in late 2013, invited to the interview stage of College selection for specialist the decision was made not to have training. This year there were more than 250 applicants for fewer an Annual Scientific Meeting in than 80 positions in Australia (New Zealand completed their 2014. This has led to an increased parallel process earlier). So many current Fellows, not least the focus on the Regional Scientific author of these words, would have really struggled to achieve Meetings in 2014: Provincial Fellows selection under such intense competition. Disappointment merges in Port Lincoln, Queensland-NSW on with incredulity when an outstanding doctor misses out on his/her the Gold Coast, WA-SA in Broome ambition to begin a career in obstetrics and gynaecology. So what and Victoria-Tasmania in Melbourne. is the process? Prof Michael Permezel These are all important events in the College calendar, with high- In essence, selection for any position in the workforce must rely President quality scientific content and great on a written application accompanied by a curriculum vitae, camaraderie among attendees. referee reports and an interview. The curriculum vitae is scored, Each was superbly organised by Fellows, supported by College but relatively little differentiates prospective Trainees. Rurality, staff, with the best national speakers giving many superb talks. I Indigenous background or a brilliant academic record identify encourage you all to support your regional meetings in the future only a few. Almost all meet the criterion related to experience in – as well as the 2015 ASM in Brisbane. obstetrics and gynaecology. Referee reports are highly structured, SAVE THE DATE! UGSA UROGYNAECOLOGICAL SOCIETY OF AUSTRALASIA ANNUAL SCIENTIFIC & GENERAL MEETING 13 – 14 MARCH 2015 THE GRACE HOTEL, SYDNEY AUSTRALIA Following the unprecedented Join the meeting wait list success of the March 2014 to receive updates as they UGSA ASM in Melbourne, become available, contact: we are proud to announce the next UGSA ASM being held in Debra O’Brien Sydney, Australia. UGSA Administrator Featuring: [email protected] - International Key Note Speakers incl. +61 3 9417 1699 Professor Ingrid Nygaard, from the USA www.ugsa.org.au - State-of-the-art lectures with generous discussion time for delegates - Popular topics in office urogynaecology and surgical therapies - Debates on controversies in urogynaecology Vol 16 No 3 Spring 2014 5 The College but almost invariably the referees rate their prospective Trainees very highly across all areas. Challenging interview questions are developed by the selection subcommittee and are uniform across all interview panels. Any selection process will never be perfect and the selection process of all the specialist colleges will inevitably come under increased scrutiny as the tsunami of young medical graduates seek specialist training in a competitive environment that can only be described as extreme. The College will strive to further improve its processes with the objective of being both fair and transparent – but also with the intention of trying to select the best possible future specialists in obstetrics and gynaecology. ‘The College will strive to further improve its processes with the objective of being both fair and transparent – but also with the intention of trying to select the best possible future specialists in obstetrics and gynaecology.’ Women’s health Morcellation and mesh Morcellation of fibroids and mesh for pelvic organ prolapse are two issues that have attracted much recent publicity. This is, in part, because of some adverse outcomes, but more particularly following news statements from the US Food and Drug Administration (FDA) such as: the ‘FDA discourages use of laparoscopic power morcellation for removal of uterus or uterine fibroids.’ The College clearly has a role to play in communicating accurate information to Fellows through such avenues as its website, electronic newsletter (Collegiate), journals and scientific meetings. Importantly, there is also a role for the College in limiting unfounded alarm, such as when urinary continence procedures involving tape had been inappropriately grouped in the same context as mesh procedures for pelvic organ prolapse. The College is indebted to members of the Women’s Health Committee and also to experts such as Prof Malcolm Frazer (Chair of the Urogynaecology Subspecialty Committee) and A/Prof Anusch Yazdani (Vice-President, AGES), who have greatly assisted in the development of College responses to these important issues. National Cervical Screening Program Members and Trainees are by now aware of the planned changes to the National Cervical Screening Program (NSCP).
Load more

Recommended publications
  • Japan Society of Gynecologic Oncology Guidelines 2015 for the Treatment of Vulvar Cancer and Vaginal Cancer
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Tsukuba Repository Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cancer and vaginal cancer 著者 Saito Toshiaki, Tabata Tsutomu, Ikushima Hitoshi, Yanai Hiroyuki, Tashiro Hironori, Niikura Hitoshi, Minaguchi Takeo, Muramatsu Toshinari, Baba Tsukasa, Yamagami Wataru, Ariyoshi Kazuya, Ushijima Kimio, Mikami Mikio, Nagase Satoru, Kaneuchi Masanori, Yaegashi Nobuo, Udagawa Yasuhiro, Katabuchi Hidetaka journal or International Journal of Clinical Oncology publication title volume 23 number 2 page range 201-234 year 2018-04 権利 (C) The Author(s) 2017. This article is an open access publication This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons. org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. URL http://hdl.handle.net/2241/00151712 doi: 10.1007/s10147-017-1193-z Creative Commons : 表示 http://creativecommons.org/licenses/by/3.0/deed.ja Int J Clin Oncol (2018) 23:201–234 https://doi.org/10.1007/s10147-017-1193-z SPECIAL ARTICLE Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cancer and vaginal cancer Toshiaki Saito1 · Tsutomu Tabata2 · Hitoshi Ikushima3 · Hiroyuki Yanai4 · Hironori Tashiro5 · Hitoshi Niikura6 · Takeo Minaguchi7 · Toshinari Muramatsu8 · Tsukasa Baba9 · Wataru Yamagami10 · Kazuya Ariyoshi1 · Kimio Ushijima11 · Mikio Mikami8 · Satoru Nagase12 · Masanori Kaneuchi13 · Nobuo Yaegashi6 · Yasuhiro Udagawa14 · Hidetaka Katabuchi5 Received: 29 August 2017 / Accepted: 5 September 2017 / Published online: 20 November 2017 © The Author(s) 2017.
    [Show full text]
  • Comparison of the Management of Vaginal Complaints in General Practice to a Protocol
    Comparison of the management of vaginal complaints in general practice to a protocol Introduction of the cervix, which are often caused by sexually transmitted pathogens, are less In the 'Standards' program of the Dutch easy to diagnose . Both a 'broad' approach College of General Practitioners, Stand­ and a strategy based on microbiological L. WIGERSMA ards (sets of guidelines) for quality medi­ diagnosis appear to besuitable for general cal care are developed.I 2 The Standards practice. The patient 's choice may often be Wigersma L. Comparison of the manage­ project was preceded by a research pro­ decisive . Variations in every phase of the ment of vaginal complaints in general prac­ gram for assessment of the feasibility and process ofcare can be accounted for. tice to a protocol. Huisarts Wet 1993; utility in daily practice of protocols for In this article, the diagnostic and thera­ 36(Suppl): 25·30. common conditions (the Protocols Pro­ peutic approach of vaginal disease in ject).' Decisive elements in the process of general practices in Amsterdam, the Abstract A protocol was developed for the problem solving (prior probability, prog­ Netherlands, is described and compared to approach of vaginal complaints, common con­ nosis, the efficacy of diagnostic tests and the corresponding elements of the proto­ ditions in general practice (GP). The manage­ ment of vaginal complaints in general practices treatments, and the influence of contextual col. The comparison specifically deals in Amsterdam, the Netherlands, was studied. factors such as the relationship between with the use and efficacy of office labora­ The diagnostic and therapeutic approach is de­ doctor and patient) are included in proto­ tory tests, microbiological tests, presump­ scribed and compared to the protocol.
    [Show full text]
  • Prevalence of Bacterial Vaginosis Among Patients with Vulvovaginitis in a Tertiary Hospital in Port Harcourt, Rivers State, Nigeria
    Asian Journal of Medicine and Health 7(4): 1-7, 2017; Article no.AJMAH.36736 ISSN: 2456-8414 Prevalence of Bacterial Vaginosis among Patients with Vulvovaginitis in a Tertiary Hospital in Port Harcourt, Rivers State, Nigeria 1 1* 1 1 1 K. T. Wariso , J. A. Igunma , I. L. Oboro , F. A. Olonipili and N. Robinson 1Department of Medical Microbiology and Parasitology, University of Port Harcourt Teaching Hospital, Nigeria. Authors’ contributions This work was carried out in collaboration between the authors. Author KTW designed the study and wrote the protocol. Author FAO wrote the first draft of the manuscript. Authors JAI and NR managed the literature search and performed statistical analysis. Author ILO managed the analysis of the study. All authors read and approved the final manuscript. Article Information DOI: 10.9734/AJMAH/2017/36736 Editor(s): (1) Jaffu Othniel Chilongola, Department of Biochemistry & Molecular Biology, Kilimanjaro Christian Medical University College, Tumaini University, Tanzania. Reviewers: (1) Olorunjuwon Omolaja Bello, College of Natural and Applied Sciences, Wesley University Ondo, Nigeria. (2) Ronald Bartzatt, University of Nebraska, USA. Complete Peer review History: http://www.sciencedomain.org/review-history/21561 Received 12th September 2017 Accepted 12th October 2017 Original Research Article Published 25th October 2017 ABSTRACT Background: Bacterial vaginosis (BV) is one of the three common causes of vulvovaginitis in women of child bearing age, usually resulting from alteration the normal vaginal microbiota and PH. Common clinical presentation includes abnormal vaginal discharge, pruritus, dysuria and dyspareunia. Aims: To determine the prevalence of bacterial vaginosis among symptomatic women of child bearing age that attended various outpatient clinics in the university of Port Harcourt teaching Hospital.
    [Show full text]
  • Update on Vaginal Infections
    PROGRESOS DE Obstetricia y Revista Oficial de la Sociedad Española Ginecología de Ginecología y Obstetricia Revista Oficial de la Sociedad Española de Ginecología y Obstetricia Prog Obstet Ginecol 2019;62(1):72-78 Revisión de Conjunto Update on vaginal infections: Aerobic vaginitis and other vaginal abnormalities Actualización en infecciones vaginales: vaginitis aeróbica y otras alteraciones vaginales Gloria Martín Saco, Juan M. García-Lechuz Moya Servicio de Microbiología. HGU Miguel Servet. Zaragoza Abstract It is estimated that abnormal vaginal discharge cannot be attributed to a clear infectious etiology in 15% to 50% of cases. Some women develop chronic vulvovaginal problems that are difficult to diagnose and treat, even by specialists. These disorders (aerobic vaginitis, desquamative inflammatory vaginitis, atrophic vaginitis, and cytolytic vaginosis) pose real challenges for clinical diagnosis and treatment. Researchers have established Key words: a diagnostic score based on phase-contrast microscopy. We review reported evidence on these entities and Vaginitis. present our diagnostic experience based on the correlation with Gram stain. We recommend treatment with Aerobic vaginitis. an antibiotic that has a very low minimum inhibitory concentration against lactobacilli and is effective against Parabasal cells. enterobacteria and Gram-positive cocci, which are responsible for these entities (aerobic vaginitis and desqua- Diagnosis. mative inflammatory vaginitis). Resumen Se estima que entre el 15 y el 50% de las mujeres que tienen trastornos del flujo vaginal, éstos no pueden atri- buirse a una etiología infecciosa clara. Algunas de ellas desarrollarán problemas vulvovaginales crónicos difíciles de diagnosticar y tratar, incluso por especialistas. Son trastornos que plantean desafíos reales en el diagnóstico Palabras clave: clínico y en su tratamiento como la vaginitis aeróbica, la vaginitis inflamatoria descamativa, la vaginitis atrófica y la vaginitis citolítica.
    [Show full text]
  • The Older Woman with Vulvar Itching and Burning Disclosures Old Adage
    Disclosures The Older Woman with Vulvar Mark Spitzer, MD Itching and Burning Merck: Advisory Board, Speakers Bureau Mark Spitzer, MD QiagenQiagen:: Speakers Bureau Medical Director SABK: Stock ownership Center for Colposcopy Elsevier: Book Editor Lake Success, NY Old Adage Does this story sound familiar? A 62 year old woman complaining of vulvovaginal itching and without a discharge self treatstreats with OTC miconazole.miconazole. If the only tool in your tool Two weeks later the itching has improved slightly but now chest is a hammer, pretty she is burning. She sees her doctor who records in the chart that she is soon everyyggthing begins to complaining of itching/burning and tells her that she has a look like a nail. yeast infection and gives her teraconazole cream. The cream is cooling while she is using it but the burning persists If the only diagnoses you are aware of She calls her doctor but speaks only to the receptionist. She that cause vulvar symptoms are Candida, tells the receptionist that her yeast infection is not better yet. The doctor (who is busy), never gets on the phone but Trichomonas, BV and atrophy those are instructs the receptionist to call in another prescription for teraconazole but also for thrthreeee doses of oral fluconazole the only diagnoses you will make. and to tell the patient that it is a tough infection. A month later the patient is still not feeling well. She is using cold compresses on her vulva to help her sleep at night. She makes an appointment. The doctor tests for BV.
    [Show full text]
  • Insights Into the Urogenial Microbiome of Females Suffering from Infectious
    From the Department of Infectious Diseases and Microbiology of the University of Lübeck Director: Prof. Dr. med. Jan Rupp The cervical microbiome in female infectious infertility: clinical trial and experimental mouse models Dissertation for Fulfillment of Requirements for the Doctoral Degree of the University of Lübeck from the Department of Natural Sciences Submitted by Simon Graspeuntner from Oberndorf b. Sbg. (Austria) Lübeck 2016 First referee: Prof. Dr. med. Jan Rupp Second referee: Prof. Dr. rer. nat. Ulrich Schaible Date of oral examination: 26.06.2017 Approved for printing: Lübeck, 06.07.2017 Table of content P a g e | I Table of content Abstract ........................................................................................................................... 1 Zusammenfassung .......................................................................................................... 3 1 Introduction .................................................................................................................... 5 1.1 Female infectious infertility ............................................................................................. 5 1.1.1 Female infertility is an important worldwide health issue .............................................. 5 1.1.2 Sexually transmitted diseases cause tubal factor infertility ............................................ 5 1.2 The microbiome of the female urogenital tract .............................................................. 7 1.2.1 Characterization of the vaginal microbiota
    [Show full text]
  • Vulvar Disease: Overview of Diagnosis and Management for College Aged Women
    Vulvar Disease: Overview of Diagnosis and Management for College Aged Women Lynette J. Margesson MD FRCPC ACHA 2013 Annual Meeting, May 30, 2013 No Conflicts of interest Lynette Margesson MD Little evidence based treatment Most information is from small open trials and clinical experience. Most treatment discussed is “off-label” Why Do Vulvar Disease ? Not taught Not a priority Takes Time Still an area if taboo VULVAR CARE IS COMMONLY UNAVAILABLE For women this is devastating Results of Poor Vulvar Care Women : - suffer with undiagnosed symptoms - waste millions of dollars on anti-yeasts - hide and scratch - endure vulvar pain and dyspareunia - are desperate for help VULVA ! What is that? Down there? Vulvar Education Lets eliminate the “Down there” generation Use diagrams and handouts See www.issvd.org - patient education Recognize Normal Anatomy Normal vulvar anatomy Age Race Hormones determine structure - Size & shape - Pigmentation -Hair growth History A good,detailed,accurate history All previous treatment Response to treatment All medications, prescribed and over-the-counter TAKE TIME TO LISTEN Genital History in Women Limited by: embarrassment lack of knowledge social taboos Examination Tips Proper visualization - light + magnification Proper lighting – bright, but no glare Erythema can be normal Examine rest of skin, e.g. mouth, scalp and nails Many vulvar diseases scar, not just lichen sclerosus Special Anatomic Variations Sebaceous hyperplasia ectopic sebaceous glands Vulvar papillomatosis Pre-anesthesia – BIOPSY use a topical
    [Show full text]
  • Erosive Lichen Planus Affecting the Vulva
    EROSIVE LICHEN PLANUS AFFECTING THE VULVA: Defining the disease, developing outcome measures and designing a randomised controlled trial Rosalind C Simpson BMedSci, BMBS, MRCP(UK) Thesis submitted to the University of Nottingham for the degree of Doctor of Philosophy December 2014 Abstract Erosive lichen planus (ELP) is a chronic, inflammatory, scarring skin condition that occurs predominantly on the mucosal surfaces of the mouth and genital region. It is believed to be an autoimmune condition although the exact pathogenesis remains unclear. This thesis focuses on ELP affecting the vulvovaginal region (ELPV). This is a rare condition with unknown incidence and prevalence. It causes painful raw areas at the vaginal entrance and subsequent scarring leads to anatomical changes with narrowing of the vaginal canal. Symptoms lead to difficulty in normal daily activities such as walking/sitting, washing, going to the toilet and can prevent normal sexual function. There is risk of cancerous change in affected skin of 1-3%. A Cochrane Systematic Review of interventions for mucosal erosive lichen planus, published in 2012, found no randomised controlled trials (RCT) on which to base treatment for ELPV. Evidence for treatments has historically been based upon retrospective case- series and case reports. Retrospective case series suggest that super-potent topical corticosteroids an effective first-line therapy, although one third of patients fail to respond adequately and require I Abstract escalation of therapy. There is no agreement for which second-line agents should be used and this is where the greatest clinical need for therapeutic guidance exists. The objective of this PhD was to begin to standardise practice for the management of people with ELPV and then develop a pragmatic protocol for those individuals who had failed to adequately respond to first line therapy with super-potent topical corticosteroids.
    [Show full text]
  • Vulvodynia: Definition, Prevalence, Impact, and Pathophysiological Factors
    Vulvodynia: Definition, Prevalence, Impact, and Pathophysiological Factors Caroline F. Pukall, PhD,1,a Andrew T. Goldstein, MD,2,a Sophie Bergeron, PhD,3 David Foster, MD,4 Amy Stein, DPT,5 Susan Kellogg-Spadt, PhD,6 and Gloria Bachmann, MD7 ABSTRACT Introduction: Vulvodynia constitutes a highly prevalent form of chronic genital pain in women, and current information regarding its definition, prevalence, impact, and pathophysiologic factors involved is needed. Aim: To update the scientific evidence published in 2010 from the Third International Consultation of Sexual Medicine pertaining to the definition, prevalence, impact, and pathophysiologic factors of women’s sexual pain. Methods: An expert committee, as part of the Fourth International Consultation of Sexual Medicine, comprised of researchers and clinicians from biological and social science disciplines, reviewed the scientific evidence on the definition, prevalence, impact, and pathophysiologic factors related to chronic genital pain. Main Outcome Measures: A review of the definition, prevalence, impact, and pathophysiological factors involved in vulvodynia. Results: Vulvodynia is a prevalent and highly impactful genital pain condition. Numerous factors have been implicated in its development and maintenance. Conclusion: What is becoming increasingly apparent is that it likely represents the end point of different factors that can differ from patient to patient. Longitudinal research is needed to shed light on risk factors involved in the expression of vulvodynia, as well as in potential subgroups of affected patients, in order to develop an empirically supported treatment algorithm. J Sex Med 2016;13:291e304. Copyright Ó 2016, International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved. Key Words: Vulvodynia; Sexual Pain; Vestibulodynia; Prevalence; Definition; Pathophysiologic Factors; Dyspareunia DEFINITION deep pelvic areas.
    [Show full text]
  • GCPR on Endometriosis
    GOOD CLINICAL PRACTICE RECOMMENDATIONS ON ENDOMETRIOSIS Theme: Enigmatic Disease - Educate Empower and Eradicate Editorial grant from Jagsonpal FOGSI GOOD CLINICAL PRACTICE RECOMMENDATIONS ON ENDOMETRIOSIS Under the agesis of FOGSI Endometriosis Committee 2014 – 2016 Convener: Dr.AlkaKriplani, President FOGSI 2016 – New Delhi Vice Presidents in-charge: Dr.Sadhana Gupta, Gorakhpur Dr.BharatiDhorepatil, Pune Assistant Secretary FOGSI 2016 Dr. Garima Kachhawa, Co – ordinator: Dr. T. Ramani Devi, Chairperson Endometriosis Committee 2014 – 2016, Trichy Editorial Assistant: Dr.SripriyaPragasam, Trichy Experts: Dr.Basab Mukherjee, Kolkata Dr.Bhaskar Pal, Kolkata Dr.SunitaTandulwadhkar, Pune Dr.NeerjaBhatla, New Delhi Dr.Aparna Sharma, New Delhi Dr.RekhaKurian, Chennai Dr.KananYelikar, Aurangabad Dr.KanthiBansal, Ahmedabad Dr.ManjuVerma, Allahabad Dr. Vinita Das, Lucknow Dr. Mala Arora, Faridabad Dr. Sonia Malik, New Delhi INDEX 1. Diagnosis of Endometriosis 2. Adolescent Endometriosis 3. Endometriosis and Infertility 4. Medical management of Endometriosis 5. Surgical management of Endometriosis 6. Pain management of Endometriosis 7. Recurrent Endometriosis 8. Endometriosis and Malignancy 9. Asymptomatic Endometriosis 10. Adenomyosis 11. Scar Endometriosis Introduction Endometriosis is an enigmatic disease. As per definition it is the presence of endometrial glands and stroma, outside the uterine cavity which induces chronic inflammatory reaction. General incidence is around 10 % of the women of reproductive age group. Among the infertile women
    [Show full text]
  • Vulval Disease - Flash Card Set
    VULVAL DISEASE - FLASH CARD SET British Society for the study of Vulval Disease www.bssvd.org Overview This set of flash cards was developed to help women’s healthcare providers (doctors, nurses) improve their skills in the assessment and management of vulval disease. These cards can be used as a training tool to improve those skills with regards lesion description, making a diagnosis and treatment options. The cards are by no means comprehensive but are designed to stimulate discussion and increase self-knowledge. About This Card Set This card set contains flash cards, which are numbered to allow the trainee or trainer to track which cards were viewed during an exercise. The front of each card displays a colour version of the vulval image and questions. The back of the card has the questions with short note form answers. There are also other relevant points of interest on the disease with additional information on prognosis and complications if relevant. Algorithm for the management of vulval itch and pain Lesion(s) to see (eg ulcer, lump, Vulval itch indurated Vulval ‘pain’ area) consider Discharge or weepy skin? biopsy Yes No Rash/ redness? Ye s No Swab and treat Is the architecture normal? Esp candida Provoked pain on touch? Yes No Yes No Lichen sclerosus Fissure? Provoked Eczema/ psoriasis Unprovoked Lichen planus Vaginismus? vulvodynia Emollients and topical vulvodynia Emollients and (Vestibulodynia) steroids Psychosexual topical steroids referral? Other regional pain syndromes? GP and Pain clinic? Vaginal oestrogen Refer if not confidence, non-responder, complicated disease FLASH CARD No. 1 What is the likely diagnosis? What signs in the picture suggest this diagnosis? How is the condition diagnosed? What is the most likely treatment? Produced by the Education and Training Group, British Society for the Study of Vulval Disease www.bssvd.org Images copyrighted - reprinted c permission from the owner FLASH CARD No.
    [Show full text]
  • Non-Candidal Vaginitis: a Comprehensive Approach to Diagnosis & Management
    1 Non-Candidal Vaginitis: A Comprehensive Approach to Diagnosis & Management Chemen M. Neal, MD1 Ms. Lauren H. Kus, BA1 Linda O. Eckert, MD2 Jeffrey F. Peipert, MD, PhD1 Indiana University School of Medicine, Indianapolis, IN1 The University of Washington, Seattle, WA2 The authors report no conflict of interest. Corresponding Author: Chemen M. Neal, MD Department of Obstetrics & Gynecology Indiana University School of Medicine 550 N University Blvd., UH2440 Indianapolis, IN 46208 Email: [email protected] Phone: (317) 944-8609 Fax: (317) 944-7417-6722 Abstract Word Count: 232 Manuscript Word Count: 3,848 ____________________________________________________ This is the author's manuscript of the article published in final edited form as: Neal, C. M., Kus, L. H., Eckert, L. O., & Peipert, J. F. (2019). Non-Candidal Vaginitis: A Comprehensive Approach to Diagnosis & Management. American Journal of Obstetrics and Gynecology. https://doi.org/10.1016/j.ajog.2019.09.001 2 CONDENSATION This article presents a comprehensive description of the causes, evaluation, and treatment of non-candidal vaginitis. Short title: Non-Candidal Vaginitis Review 3 ABSTRACT Vaginitis is one of the most common causes of patient visits to gynecologists, primary care providers, and urgent care centers. However, many women leave without a clear diagnosis or experience recurrent symptoms despite treatment. The three most common etiologies of vaginitis are trichomonas, bacterial vaginosis, and vulvovaginal candidiasis, which account for an estimated 70% of cases. The remaining 30% may be related to other causes of vaginitis, including atrophic vaginitis, desquamative inflammatory vaginitis, and vaginal erosive disease. The purpose of this review is to describe the non-candidal causes of acute and recurrent vaginitis, with the goal of improving the likelihood of accurate diagnosis as well as efficient and effective therapy.
    [Show full text]